Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokines in glomerulonephritis.

Peter G Tipping1, Stephen R Holdsworth

  • 1Centre for Inflammatory Diseases, Department of Medicine, Monash Institute for Medical Research, Monash University, Clayton, Victoria, Australia. peter.tipping@med.monash.edu.au

Seminars in Nephrology
|May 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toll-like Receptor 9 Induced Dendritic Cell Activation Promotes Anti-Myeloperoxidase Autoimmunity and Glomerulonephritis.

International journal of molecular sciences·2023
Same author

Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus Erythematosus.

Human gene therapy·2022
Same author

Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria.

Frontiers in immunology·2022
Same author

Ageing enhances cellular immunity to myeloperoxidase and experimental anti-myeloperoxidase glomerulonephritis.

Rheumatology (Oxford, England)·2021
Same author

BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity.

Frontiers in immunology·2021
Same author

Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune Diseases.

Frontiers in immunology·2021
Same journal

Current Options for Kidney Protection: Are Renin-Angiotensin System Inhibitors Still Relevant?

Seminars in nephrology·2026
Same journal

Proposed Role for Quantitative Podocyturia as a Clinical Marker of Systemic Endothelial Injury: Implications for Cardiovascular Disease and Longevity.

Seminars in nephrology·2026
Same journal

Kidney Protection Options in 2025: Are Renin-Angiotensin System Inhibitors Still Needed?

Seminars in nephrology·2026
Same journal

From Nephron Number to Global Health.

Seminars in nephrology·2026
Same journal

Chronic Kidney Disease Progression Mechanisms: Why They Matter in an Era of Novel Kidney Protective Therapies.

Seminars in nephrology·2026
Same journal

Of Diuretics, Transporters, and Mechanisms of Hypertension.

Seminars in nephrology·2026
See all related articles

Cytokines are key drivers of kidney inflammation and damage in glomerulonephritis (GN). Targeting these immune signaling molecules shows promise for treating human GN.

Area of Science:

  • Immunology
  • Nephrology
  • Molecular Biology

Background:

  • Cytokines mediate innate and adaptive immunity, crucial for initiating and modulating renal inflammation.
  • They orchestrate systemic immune cell interactions and intrarenal signaling, contributing to nephritogenic immune responses.

Purpose of the Study:

  • To elucidate the multifaceted roles of cytokines in the pathogenesis of glomerulonephritis (GN).
  • To highlight the significance of cytokine modulation in both animal models and human GN, and explore therapeutic potential.

Main Methods:

  • Review of animal models and clinical studies on cytokine involvement in GN.
  • Analysis of cytokine signaling pathways between infiltrating leukocytes and intrinsic renal cells.
  • Examination of T helper 1/T helper 2 balance modulation by cytokines in nephritogenic immunity.

Related Experiment Videos

Main Results:

  • Cytokines are critical for initiating and modulating renal inflammation, influencing the T helper 1/T helper 2 balance in GN.
  • Both infiltrating leukocytes and intrinsic renal cells produce cytokines that amplify intrarenal inflammation.
  • Clinical evidence confirms the paradigm of cytokine involvement in human GN's mechanisms, patterns, and outcomes.

Conclusions:

  • Cytokines are central to the development, perpetuation, and resolution of GN.
  • Intrarenal cytokine production by both immune and renal cells significantly contributes to GN pathogenesis.
  • Targeting specific cytokines, such as tumor necrosis factor, demonstrates therapeutic benefits in human GN.